Screener
Bio-Techne Corp. TECH Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65.8%+1.0pp | 65%-0.8pp | 65.2%-0.4pp | 65.4%-0.1pp | 64.8%-1.6pp | |
| Operating margin | 20.7%— | —— | —— | —— | —— | |
| Net margin | 15%— | —— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 9%— | —— | —— | —— | —— | |
| Return on invested capital | 8.8%— | —— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.5×+1.1× | 4.5×+0.8× | 4.5×+0.6× | 4.2×-0.3× | 3.5×-0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0.1×-0.1× | 0.2×0.0× | —— | 0.2×0.0× | |
| Net debt / EBITDA | 0.1×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $13.43+11.8% | $13.25+4.3% | $12.81-1.0% | —— | $12.01-6.6% | |
| Valuation | ||||||
| Market capitalization | $11.35B+17.4% | $8.18B-11.8% | $9.16B-19.9% | $8.66B-31.4% | $7.84B-30.5% | |
| Price / earnings | 62.4×— | —— | —— | —— | —— | |
| Price / sales | 9.3×+1.4× | 6.8×-0.9× | 7.5×-2.0× | 7.1×-3.7× | 6.4×-3.3× | |
| Price / book | 5.4×— | 3.9×-0.7× | 4.6×-0.9× | —— | 4.1×-1.4× | |
| EV / EBITDA | 32.6×— | —— | —— | —— | —— | |
| Dividend yield | 0.4%-0.1pp | 0.6%+0.1pp | 0.5%+0.1pp | 0.6%+0.2pp | 0.6%+0.2pp |
FAQ
- What are Bio-Techne Corp.'s profit margins?
- Bio-Techne Corp. (TECH) runs a 65.8% gross margin and a 20.7% operating margin, with a 15.0% net margin.
- Where do Bio-Techne Corp.'s ratios come from?
- Every ratio is computed from Bio-Techne Corp.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
